Rajnish Mago, MD
Director, Mood Disorders Program
Assistant Professor, Psychiatry and Human Behavior

Contact Dr. Mago

833 Chestnut East, Suite 210
Philadelphia, PA 19107

(215) 955-9474
(215) 503-5698 (fax)

Medical School
King George's Medical College, University of Lucknow, Lucknow, India (1988)

Residency
University of Pennsylvania, Philadelphia, PA (1998)

Board Certification
American Board of Psychiatry and Neurology, Certified in Psychiatry
American Board of Psychiatry and Neurology, Psychosomatic Medicine

University Appointment
Assistant Professor, Psychiatry and Human Behavior

Research and Clinical Interests
Evaluation and treatment of Mood disorders including Depressive disorders ("depression") and Bipolar disorder; Evaluation and treatment of Treatment-resistant mood disorders; Evaluation and treatment of side effects of medications, including Excessive sweating; Psychotherapy for the treatment of chronic (long-standing) clinical depression; Second-opinion consultations regarding diagnosis and treatment of Mood disorders; Novel approaches to identification and assessment of side effects of medications; Novel approaches to treatment of various side effects of psychiatric medications; Clinical trials of new medications for the treatment of Mood disorders; Practical strategies for the teaching and practice of evidence-based medicine

Publications

1. Bipolar disorder questionnaire [12]
2. Older patients and health care utilization [4] (multiple letters)
3. Proposed strategies for successful clinical management with aripiprazole
4. Medically serious adverse effects of newer antidepressants
5. Urinary retention associated with ziprasidone: A case report
6. Antiadrenergic treatment of antidepressant-induced excessive sweating in 3 patients [6]
7. An open-label, rater-blinded, augmentation study of aripiprazole in treatment-resistant depression
8. Recurrent priapism associated with use of aripiprazole [2]
9. Tardive dystonia-associated prescription of aripiprazole
10. Anxiety in medically ill patients
11. Zonisamide-induced suicidal ideation
12. Periodic restless legs syndrome associated with quetiapine use: A case report [6]
13. Injection site pain with long-acting risperidone [2] (multiple letters)
14. Psychosocial oncology: Supportive care for the cancer patient
15. Use of long-acting risperidone [1] (multiple letters)
16. Psychotic symptoms in patients with medical disorders
17. Searching the medical literature for case reports.